Galecto (GLTO) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free GLTO Stock Alerts $0.61 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Galecto Stock Price Performance5 Day Performance-2.44%1 Month Performance-15.20%3 Month Performance-25.85%6 Month Performance+1.33%Year-To-Date Performance-15.56%1 Year Performance-72.24% Receive GLTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galecto and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. GLTO Stock Chart for Sunday, June, 2, 2024 GLTO Chart by TradingView Galecto Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.61$0.61-0.33%$0.62$0.6071,933 shs$16.48 million05/30/2024$0.61$0.61-0.36%$0.62$0.60140,748 shs$16.54 million05/29/2024$0.62$0.61-1.77%$0.62$0.60124,183 shs$16.60 million05/28/2024$0.63$0.62-1.06%$0.63$0.6153,729 shs$16.90 million05/27/2024$0.63$0.63$0.63$0.61100,400 shs$17.08 million05/24/2024$0.62$0.63+1.60%$0.63$0.61100,482 shs$17.08 million Get the Latest News and Ratings for GLTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galecto and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.63$0.62-0.80%$0.64$0.6199,620 shs$16.81 million05/22/2024$0.62$0.63+0.10%$0.64$0.6175,738 shs$16.94 million05/21/2024$0.63$0.62-1.36%$0.64$0.6174,497 shs$16.93 million05/20/2024$0.62$0.63+1.92%$0.64$0.6270,958 shs$17.16 million05/17/2024$0.63$0.62-1.41%$0.63$0.6244,139 shs$16.84 million05/16/2024$0.64$0.63-0.93%$0.65$0.62110,774 shs$17.08 million05/15/2024$0.68$0.64-6.49%$0.68$0.61423,450 shs$17.24 million05/14/2024$0.68$0.68-0.01%$0.69$0.66207,456 shs$18.44 million05/13/2024$0.68$0.68+0.04%$0.70$0.67144,690 shs$18.44 million05/10/2024$0.70$0.68-2.90%$0.72$0.6886,917 shs$18.43 million05/09/2024$0.71$0.70-0.70%$0.71$0.6912,190 shs$18.98 million05/08/2024$0.71$0.71-0.72%$0.72$0.6866,891 shs$19.11 million05/07/2024$0.71$0.71$0.74$0.70118,395 shs$19.25 million05/06/2024$0.70$0.71+1.43%$0.73$0.70103,630 shs$19.25 million05/03/2024$0.72$0.70-2.36%$0.74$0.7024,864 shs$18.98 million05/02/2024$0.68$0.72+5.38%$0.73$0.68280,815 shs$19.44 million05/01/2024$0.69$0.68-1.25%$0.69$0.6647,208 shs$18.45 million04/30/2024$0.70$0.69-1.84%$0.72$0.66144,773 shs$18.68 million04/29/2024$0.70$0.70-0.41%$0.72$0.6796,651 shs$19.03 million04/26/2024$0.67$0.70+4.17%$0.71$0.66119,427 shs$18.84 million04/25/2024$0.67$0.67-0.55%$0.70$0.6526,332 shs$18.09 million04/24/2024$0.70$0.67-4.22%$0.71$0.6575,622 shs$18.19 million04/23/2024$0.68$0.70+2.88%$0.70$0.68106,964 shs$18.99 million04/22/2024$0.68$0.68-0.07%$0.72$0.6861,412 shs$18.46 million04/19/2024$0.72$0.68-5.35%$0.72$0.6876,564 shs$18.48 million04/18/2024$0.67$0.72+6.76%$0.72$0.65107,127 shs$19.52 million04/17/2024$0.68$0.67-0.59%$0.69$0.6560,222 shs$18.29 million04/16/2024$0.69$0.68-1.29%$0.68$0.6423,625 shs$18.39 million04/15/2024$0.68$0.69+0.93%$0.69$0.64111,894 shs$18.63 million04/12/2024$0.70$0.68-2.73%$0.72$0.68233,119 shs$18.46 million04/11/2024$0.68$0.70+2.96%$0.74$0.6697,192 shs$18.98 million04/10/2024$0.71$0.68-4.82%$0.71$0.65173,672 shs$18.44 million04/09/2024$0.71$0.71+0.14%$0.72$0.6866,609 shs$19.37 million04/08/2024$0.76$0.71-6.13%$0.79$0.60396,556 shs$19.34 millionThe Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.04/05/2024$0.73$0.76+4.10%$0.79$0.71317,606 shs$20.60 million04/04/2024$0.75$0.73-2.03%$0.77$0.7378,616 shs$19.79 million04/03/2024$0.77$0.75-2.60%$0.78$0.73124,797 shs$20.20 million04/02/2024$0.75$0.77+2.68%$0.78$0.7490,017 shs$20.74 million04/01/2024$0.78$0.75-4.49%$0.80$0.74162,690 shs$20.20 million03/29/2024$0.78$0.78$0.82$0.77129,262 shs$21.15 million03/28/2024$0.78$0.78$0.82$0.77128,972 shs$21.15 million03/27/2024$0.74$0.78+5.08%$0.84$0.74764,951 shs$21.15 million03/26/2024$0.74$0.74+0.08%$0.77$0.7438,896 shs$20.12 million03/25/2024$0.78$0.74-5.38%$0.78$0.74126,643 shs$20.11 million03/22/2024$0.77$0.78+2.34%$0.79$0.7465,767 shs$21.25 million03/21/2024$0.79$0.77-2.92%$0.79$0.7567,998 shs$20.77 million03/20/2024$0.76$0.79+3.82%$0.80$0.7750,312 shs$21.39 million03/19/2024$0.77$0.76-1.61%$0.82$0.76160,617 shs$20.60 million03/18/2024$0.82$0.77-5.56%$0.82$0.7762,440 shs$20.94 million03/15/2024$0.76$0.82+7.18%$0.82$0.7592,908 shs$22.17 million03/14/2024$0.75$0.76+1.60%$0.78$0.73259,654 shs$20.69 million03/13/2024$0.79$0.75-4.78%$0.83$0.75199,610 shs$20.37 million03/12/2024$0.79$0.79-0.13%$0.82$0.74327,613 shs$21.38 million03/11/2024$0.87$0.79-9.23%$0.88$0.76257,778 shs$21.41 million03/08/2024$0.85$0.87+2.49%$0.94$0.84377,370 shs$23.59 million03/07/2024$0.89$0.85-4.66%$0.90$0.77359,328 shs$23.02 million03/06/2024$0.81$0.89+9.95%$0.91$0.78380,103 shs$24.14 million03/05/2024$0.87$0.81-6.89%$0.88$0.79419,999 shs$21.96 million03/04/2024$0.82$0.87+6.07%$0.92$0.80888,646 shs$23.58 million03/01/2024$0.72$0.82+13.86%$0.85$0.681.28 million shs$22.23 million Related Companies: Lantern Pharma Stock Chart Celularity Stock Chart Viveon Health Acquisition Stock Chart MediciNova Stock Chart Checkpoint Therapeutics Stock Chart Rallybio Stock Chart Affimed Stock Chart Leap Therapeutics Stock Chart Mural Oncology Stock Chart Immix Biopharma Stock Chart Receive GLTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galecto and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLTO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.